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ABSTRACT 
The present study was aimed to develop a simple and validated chromatographic method for the estimation of Trimyristin in the API and in poly 
herbal Ayurvedic formulations by UFLC method, along with stress induced degradation studies of the drug and validate the method as per the ICH 
guidelines. The analysis was carried out under isocratic conditions using dichloromethane and acetonitrile in the ratio of 95:5 as mobile phase with 
a flow rate of 1.0 ml/min at 210nm. The method was simple, specific, precise, and accurate with retention times 0.904 and 0.906 minutes for the API 
and isolated product. The system obeys the Beer's law in the concentration range of 10-90μg/ml. The percentage recovery studies performed 
showed a percentage recovery of 98.3 -101.6%w/v and found to be linear with a correlation coefficient (r2) of 0.9993. The method was found to be 
precise with relative standard deviation of less than 2%, detection limit and quantitation limit was estimated to be 4.58μg/ml, 15.27μg/ml 
respectively. The method was found to be robust even by change in mobile phase ratio of ±5%, change in wavelength and change in flow rate of ±0.1 
ml/min.  This validated method was sensitive and reproducible enough to be used for routine analysis of Poweromin tablet and Makaradhwaj vatti 
in time and cost effective manner. 
Keywords: Trimyristin, Poweromin, Makaradhwaj vatti, UFLC, isocratic elution, validation and stress degradation. 
INTRODUCTION 
The herbal medicinal science is an ancient system of medicine that is 
gaining a prominent importance in the global market.  The herbal 
plant Myristica fragrans also called as nutmeg, has many uses in 
Ayurvedic system of medicine. Myristica fragrans Houtt, traditionally 
known as Jatiphal and Javitri in India, belongs to the family 
Myristicaceae. It mainly produces two spices, nutmeg seed and mace 
the thick fiber like red aril on the kernel [1]. The herbal drug yields 
two kinds of oils i.e., the compressed fatty oil and the steam distilled 
essential oil. The main constituents of the oils of M. fragrans have 
been found to be alkyl benzene derivatives terpenes, alpha-pinene, 
beta-pinene, phenyl propanoids like myristicin, elemicin, safrole and 
fatty acids Trimyristin, myristic acid, tripalmitin etc. [2]. The 
triglyceride Trimyristin (fatty oil) was given less importance when 
compared to the essential oil part of the nutmeg mostly myristicin as 
it was believed to be responsible for the various pharmacological 
actions of the herb. So, several studies were confined to the isolation 
and usage of Trimyristin as a lipid polymer in formulations. But to 
the fact, the triglyceride Trimyristin was proven to have anxiogenic 
activity which, the principle reason of using the herbal drug in 
various polyherbal formulations [3]. Apart from this it also has other 
activities like anti-inflammatory and anti-bacterial [4-6]. Trimyristin 
is an example of fundamental type of fat known as a triglyceride. 
Hydrolysis of one mole of a triglyceride affords one mole of 1, 2, 3-
propanetriol (glycerin) and three moles of fatty acids, which are 
carboxylic acids containing the functional group at the end of a long 
alkyl chain. Chemically Trimyristin is called as 1, 3 Di 
(tetradecanolyloxy) propan-2-yl tetradecanoate [7] [Fig. 1]. 
 
Fig. 1: Chemical structure of Trimyristin 
 
The previous works reveal no specific analytical method for the 
estimation of Trimyristin quantitatively in poly herbal formulations.  
The literature survey reported various works on Trimyristin 
characterization by IR and NMR spectroscopy apart from the 
isolation of the components from the seeds and mace of Myristica 
fragrans. The previous reported works include the quantification of 
the components by HPLC, HPTLC [8-11] in various vegetable oils and 
in nutmeg seed extract and the standardization of the polyherbal 
formulations [12-13]. So, considering the need of developing a 
validated method for the estimation of trimyristin the present work 
was intended to quantify the trimyristin in the API and in poly 
herbal formulations by UFLC method and to validate the method 
according to the ICH guidelines.  
The herbal formulations include a compressed tablet named 
Poweromin and a mould named Makaradhwaj Vatti. Analytical 
validation is the cornerstone of process validation. Without a proven 
measurement system it is impossible to confirm whether the 
manufacturing process has done what it purport to do. Hence, there 
is a need to validate the new methods developed. So the present is 
being validated for various parameters according to the ICH 
guidelines. The stability of the drug in various environments was 
also studied by the stress degradation studies as per the ICH 
guidelines [14, 15]. 
MATERIALS AND METHODS 
Plant material 
The seeds of Myristica fragrans were collected from the local drug 
store. The seeds were crushed to fine powder and stored at 250C. 
Instrumentation 
The method was developed using Shimadzu LC 20 AD UFLC system 
with 20 µL loops, LC 20 AD pump, SP-20AD Photo- Diode array 
detector, Waters C8 (350µm, 4.6 x 150mm) column was used in the 
analysis. LC solutions software was utilized for instrument control, 
data collection and data processing using a Pentium (R) Dual –Core 
Processor. The analysis was carried out under isocratic conditions 
using dichloromethane and acetonitrile in the ratio of 95:5 as the 
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mobile phase with a flow rate of 1.0 ml/min at 210nm. All solvents 
were filtered through a 0.45 μm Millipore filter. A volume of 20 μL of 
the standard and samples solutions was injected into the column.  
Chemicals 
Standard Trimyristin was obtained from Himedia (RM 1301-1G), 
India. Acetonitrile and Dichloromethane were purchased from 
Merck Chemicals Ltd. Hydrogen peroxide, Sodium Hydroxide was 
purchased from SD FCL (SD Fine Chem. Limited) and Mio Chem. Pvt. 
Ltd respectively. Hydrochloric acid was obtained from Merck 
Chemicals. All other chemicals and reagents were of HPLC grade. 
The polyherbal tablets Poweromin (Apex Laboratories Pvt. Ltd.) and 
Makaradhwaj vatti (Godavari Ayurvedic Pharmacy) were obtained 
from the local ayurvedic store. 
Extraction of Trimyristin 
Crushed whole nutmeg seeds of 5gms was weighed and transferred 
to a 50ml round-bottomed flask. 50ml of hexane was added to the 
flask which was attached to a water-cooled condenser, the mixture 
was heated under a gentle reflux for approximately 4 hours at 60oC. 
The mixture was cooled to room temperature. The hexane layer was 
separated out with pipette without disturbing the settled solids. The 
hexane layer was evaporated by using rotavapour apparatus which 
on evaporation yields a white crystalline powder. The crude extract 
was recrystallised by using 95% ethanol to yield pure trimyristin. 
The extracted trimyristin was characterized by IR [Fig. 2]. 
Preparation of standard and extract stock solution 
An accurately weighed quantity of 10mg API and extract were 
transferred into two separate 10ml volumetric flasks and dissolved 
into 10ml dichloromethane to give a concentration of 1000µg/ml. 
The final concentration was brought to 10µg/ml by diluting the 
stock solution with dichloromethane, filtered through 0.45 µ 6, 6 
membrane nylon filter.  
Assay of marketed Polyherbal Ayurvedic Poweromin tablet 
Twenty tablets were weighed and ground to a fine powder using a 
mortar and a pestle.  An accurately weighed portion of the powder, 
equivalent to 5mg of drug was transferred into a 250ml round 
bottomed flask and 30ml of petroleum ether HPLC grade was added 
to it, the above solution was refluxed for 30min at 70 . The 
petroleum ether layer was separated, evaporated completely and 
diluted to 50ml with dichloromethane. From the above stock 
solution the dilutions were prepared using dichloromethane such 
that the final concentration of the solution was 10µg/ml.  
Assay of polyherbal Ayurvedic Makaradhwaj Vatti tablet 
Twenty tablets were weighed and ground to a fine powder using a 
mortar and pestle. An accurately weighed portion of the powder, 
equivalent to 5mg of drug was transferred into a 250ml round 
bottomed flask and added with 10 ml of water, 30ml of 
dichloromethane respectively. The above solution was sonicated for 
20min at 60  and centrifuged for 5 minutes. The dichloromethane 
layer was separated and diluted to 50ml with the same solvent. This 
solution was further diluted to 10µg/ml with dichloromethane. 
Method Validation             
The method was validated for specificity, linearity, accuracy, 
precision, LOD, LOQ, robustness and ruggedness as per the ICH 
guidelines [14, 15]. 
Specificity 
For a chromatographic method developing a separation involves 
demonstrating specificity, which is the ability of the method to 
accurately measure the analyte response in the presence of all 
interferences. Therefore the samples were analyzed in the presence 
of interfaces and the analyte peak was evaluated for peak purity and 
resolution from the nearest eluting peaks.  
Linearity 
Nine point linearity plots were constructed for API using the 
concentrations ranging from 10µg/ml-90µg/ml. The linear 
relationship of the system was calculated through the coefficient of 
regression. 
Precision 
Precision was assessed through repeatability and intermediate 
precision. Assay precision was calculated using the formula %RSD = 
(SD/M) × 100 where M is the mean of the experimentally 
determined concentrations and SD is the standard deviation of M. 
Accuracy  
The accuracy of the method was established by using analyte at low, 
medium and high concentrations of 8µg/ml, 10µg/ml and 12µg/ml 
for trimyristin API. The percentage assay was calculated for 2 
consecutive days by preparing fresh solutions each day. 
Recovery studies 
Percentage recovery studies were performed for 80%, 100% and 
120% concentrations for both the tablets respectively for 8µg/ml, 
10µg/ml and 12µg/ml. The percentage recovery of trimyristin of the 
spiked samples of herbal formulation was calculated. 
Robustness  
Robustness of the method was determined by slight deviation in the 
method parameters. The parameters deviation wavelength, flow 
rate, and mobile phase were selected. Robustness was done by 
changing the flow rate (±0.1ml/min), changing the wavelength 
(±1nm), and organic composition of mobile phase (±5%).  
System Suitability 
The chromatographic parameters such as selectivity, theoretical 
plates and tailing factor were determined for trimyristin with five 
replicate injections.  
LOD and LOQ 
Standard stock solutions were diluted appropriately to obtain 
concentrations for the estimation of the limit of detection (LOD) and 
limit of quantitation (LOQ) according to a signal to noise (S/N) ratio 
of 3:1 and 10:1 respectively. 
Stress degradation studies 
The stress degradation studies such as hydrolytic (in acidic & alkali 
medium), photolytic, oxidation and dry heat induced degradation 
studies were performed for API as per ICH guidelines. All the 
solutions are injected after filtering through 0.45 µ 6, 6 membrane 
nylon filter. 
Hydrolytic degradation under acidic conditions 
Hydrolytic degradation studies under acidic conditions were 
performed by using 2ml (10µg/ml) of stock solution of trimyristin 
API in three sets of separate volumetric flasks, to this 1ml of 1N, 
0.1N, 0.01N methanolic HCl was added into each flask and volume 
was made to 10ml with dichloromethane, these solutions were kept 
at 250C, 600C for 20 min. 5ml of the above solution was further 
diluted to 10ml with dichloromethane and injected into the system. 
Hydrolytic degradation under alkaline conditions 
Hydrolytic degradation studies under alkaline conditions were 
performed by taking 2ml (100 g/ml) of stock solution of trimyristin 
API in three sets of separate volumetric flasks, to this 1ml of 1N, 
0.1N, 0.01N methanolic NaOH was added into each flask and the 
volume was made up to 10ml with dichloromethane, these solutions 
were kept at 250C and 600C for 20 min, from this 5ml of solution was 
diluted to 10ml with dichloromethane and injected into the system. 
Dry heat induced degradation 
Dry heat induced degradation studies were performed by subjecting 
10 mg of Trimyristin API in a standard volumetric flask to a 
temperature of 80oC for 48 hours in a hot air oven.  After 48 hrs the 
drug was taken out and diluted with the dichloromethane such that 
the final concentration was 5µg/ml and injected into the system. 
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Oxidative degradation studies were performed by taking 1.5 ml 
(100µg/ml) of stock solution of Trimyristin API in a 10 ml 
volumetric flask, to this 1ml of 3  hydrogen peroxide (which was 
stored for overnight) was added and the volume was made up to 
10ml with dichloromethane. This solution was kept at room 
temperature for 90 minutes and then diluted to a concentration of 
5µg/ml. The final solution was injected into the system. 
Photolytic degradation 
Photolytic degradation study was performed by exposing the 
trimyristin API to near UV light for 30 minutes in an UV chamber and 
to the daylight for 2 days. After the exposure 10 mg of drug was 
taken and diluted to a concentration of 5µg/ml using 
dichloromethane for the purpose of analysis. 
RESULTS AND DISCUSSION 
The extracted trimyristin was characterized using the FTIR 
spectroscopy by its characteristic peaks at 2900 -2700 cm-1 (C-H 
stretching), 1729 cm-1 (C=O stretching vibration of ester), 1388 cm-1 
(symmetrical deformations of CH3group), 1226cm-1, 1172 cm-1, 
1111 cm-1( asymmetrical stretching of ester C-O-C, common to all 
long chain triglycerides of long chain fatty acids), 1035 cm-1 
(symmetrical stretching of ester C-O-C), 714 cm-1 (wagging of CH2 
group) [Fig. 2]. 
Fig. 2: IR Spectrum of Sample showing the characteristic peaks 
Preliminary experiments were carried out to optimize the 
experimental parameters affecting chromatographic separation of 
Trimyristin. To obtain chromatograms with good separation various 
columns, mixtures of the mobile phase and different flow rates were 
investigated. For the assay of Trimyristin in polyherbal formulation 
Waters Prepacked C8 column with various mixtures of 
dichloromethane and acetonitrile were used as mobile phase and 
results indicated that dichloromethane and acetonitrile in a ratio of 
95:5 v/v gives the best resolution. Also using different flow rates (in 
the range of 0.8-2 ml/min) revealed that the best separation was 
achieved on a flow rate of 1.0 ml/min of mobile phase. Trimyristin 
was well separated with retention time of 0.904 for standard API 
and 0.906 for recrystallised extract [Fig. 3, 4]. The drug in polyherbal 
formulations Makaradhwaj vatti and Poweromin after extraction 
showed the prominent peak at 0.906, 0.905 respectively indicating 
the specificity of the method [Fig. 5, 6]. The percentage assay was 
determined to be 99.89%, 99.65% for Poweromin and Makaradhwaj 
vatti respectively. 
Method Validation 
The method was validated for specificity, linearity, accuracy, 
precision, robustness, system suitability, LOD, LOQ as per the ICH 
guidelines. 
 
Fig. 3:  UFLC Chromatogram of Trimyristin API 
 
Fig. 4: UFLC Chromatogram of Trimyristin extracted from the 
seeds of nutmeg 
 
Fig. 5: UFLC Chromatogram of Trimyristin extracted from the 
polyherbal formulation Makaradhwaj Vatti 
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Fig. 6: UFLC Chromatogram of Trimyristin extracted from the 
Polyherbal formulation Poweromin 
Linearity 
The linearity was observed to obey the Beer’s law in concentrations 
ranging from 10-90µg/ml.  The linear plot plotted with 
concentration against absorbance with correlation coefficient (r2) of 
0.9993 for both the API and extract for 3 successive days [Fig. 7]. 
 
Fig. 7: Linearity plot of Trimyristin API. 
Precision 
The precision was performed for the Trimyristin API standard solutions 
of concentration of 10µg/ml, 20µg/ml, 40µg/ml by injecting five times 
and basing on the area for all six injections the precision of the method 
was determined. The % RSD for the area of six replicate injections was 
found to be within 2% [Table 1, 2]. 
Table 1: Shows the peaks results for method precision 
S.No Concentration 
Retention Time Peak area 
Mean %RSD Mean %RSD 
1 10µg/ml 0.9042 0.16 447320.625 0.5 
2 20µg/ml 0.9023 0.25 447596.65 0.61 
3 40µg/ml 0.9012 0.03 447465.23 0.52 






Mean±SD %RSD Mean±SD %RSD 
API 
    10µg/ml  9.91± 0.05 0.5 9.83±0.02 0.4 
20µg/ml  19.95±0.04 0.2 19.83±0.08 0.72 
40µg/ml 39.81±0.02 0.13 39.64±0.02 0.05 
Extract  
    10µg/ml  9.8±0.01 0.15 9.62±0.05 0.61 
20µg/ml  19.92±0.03 0.4 19.59±0.09 0.53 
40µg/ml 39.93±0.06 0.35 39.39±0.03 0.64 
 API: Active Pharmaceutical Ingredient (Standard Trimyristin) 
(±SD) = Standard deviation 
Accuracy studies 
 The accuracy of the method was established by using analyte at low, 
medium and high concentrations of 8µg/ml, 10µg/ml, and 12µg/ml 
of trimyristin API, extract and polyherbal formulations. The 
percentage assay calculated for 2 consecutive days by preparing 
fresh solutions each day was found to be in the range of 98 – 102 % 
[Table 3].  
Recovery studies 
Percentage recovery studies were performed for 80%, 100% and 
120% concentrations for both the tablets by keeping the dilutions 
constant that is for 8µg/ml, 10µg/ml and 12µg/ml. The percentage 
recovery of trimyristin from the spiked sample was found to be in 
between 98.3 -101.6%w/v [Table 4]. 














( µg/ml) (µg/ml) (%) n=3 (µg/ml) (%) n=3 
 
8µg/ml 7.92 99.6 0.9 7.64 97.9 1.27 




11.93 99.6 0.94 11.62 97.7 0.45 
 
8µg/ml 8.14 101.3 0.83 8.07 100.9 0.93 
Extract 10µg/ml 9.92 99.6 0.23 10.06 101.02 0.82 
 
12µg/ml 11.82 98.8 1.18 11.97 99.8 0.91 
 
8µg/ml 7.94 99.3 0.82 7.74 98.64 1.04 




11.97 99.8 0.91 11.71 98.6 0.93 
Makaradhwaj 8µg/ml 8.04 100.6 0.63 7.85 96.9 0.68 
Vatti 10µg/ml 9.92 98.02 0.67 9.83 98.6 0.17 
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Poweromin Low 7952 8104 101.62 0.8 
 Medium 9940 9930 101.09 1.23 
 High 11928 11885 99.97 0.74 
Makaradhwaj vatti Low 7984 7942 99.53 0.42 
 Medium 9980 10080 101.23 0.83 
 High 11976 12011 100.2 1.2 
ROBUSTNESS  
Robustness of the method was determined by a slight deviation in 
the method parameters. The parameters selected were deviation in 
column chemistry, wavelength, flow rate and mobile phase. The 
retention time of trimyristin was determined and % RSD using 
system suitability parameters was observed [Table 5]. 
Table 5: Robustness Studies of Trimyristin 
Parameters %RSD 






The chromatographic parameters such as selectivity, theoretical 
plates and tailing factor were satisfactory for trimyristin. The peak 
asymmetry was calculated in terms of tailing factor, 1.09 which was 
less than the approved limit. The theoretical plates were above 2000 
(4332) for every peak of the drug. 
Limit of Detection and Limit of Quantization 
Detection limit and quantification limit was found to be 4.58μg/ml 
and15.27μg/ml by using the S/N ratios of 3:1 and 10:1 respectively. 
Stress degradation studies 
The standard API trimyristin when subjected to 0.01N, 0.1N HCl in 
case of acid induced hydrolytic studies no degradation was observed 
at 250C whereas the other set of same solutions when heated to 600C 
showed 15.6%, 28.9% degradation respectively with an additional 
peak at 0.852. 7.2% degradation was observed in case of 1N HCl at 
250C after 20 minutes with an additional peak at 0.823. The drug 
totally degraded on heating with 1N HCl mixture for 20 minutes at 
600C along with the same additional peak. In case of alkaline 
hydrolysis 0.01N, 0.1N, 1N NaOH slight degradation of 0.01%, 0.64% 
and 2.52 %was observed at 250C respectively after a period of 20 
minutes with an additional peak at 0.732 with 0.01N, 0.1N NaOH and 
1.037 with 1N NaOH. The other set of same solutions when heated at 
600C for 20 minutes the drug degraded up to 8.25%, 23.2% and 
52.4% respectively,  the chromatogram showed additional peaks at 
0.803, 1.215 apart from 0.732. The dry heat induced degradation 
studies indicated the stability of the drug at 800C for a period of 48 
hours. The solid drug was melted when subjected to a temperature 
of 800C which showed the change in the physical stability of the drug 
(M.P- 540C) without any chemical degradation. The oxidative 
degradation showed 100% degradation with degraded peaks at 
1.156 and 1.490. Under photochemical conditions the drug 
completely degraded with degraded peaks at 0.826, 1.156 and 1.356 
under UV exposure where as the daylight exposure does not show 
any prominent degradation changes. The degradation studies 
confirmed that trimyristin was more susceptible to dry heat induced 
degradation studies. A total of seven degraded peaks were observed 
[Table 6]. Peaks with higher Rt values apart from acid hydrolytic 
degradation indicated less polar nature than Trimyristin. 
Table 6: Summary of Stress Degradation Studies 
CONCLUSION 
Recent investigations have confirmed that Trimyristin has 
vulnerable and wide-ranging pharmacological properties such as 
anxiogenic, anti-inflammatory properties. So the present cost-
effective method can be used for the market analysis of trimyristin 
in polyherbal formulations and this particular stability indicated 
UFLC method was found to be simple, accurate and precise. The 
stability indicating stress degradation studies crams                     









HCL   0.01N 
HCL     0.1N 
HCL        1N 
 
 
At 250C               At 600C 
No degradation    15.6% 
No degradation     28.9% 
7.2%                      100% 
 
 
   At 250C                    At 600C 
       -                              0.852 
       -                              0.852 
     0.823                        0.832 
 
Alkaline Hydrolysis 
NaOH   0.01N 
NaOH    0.1N 
NaOH       1N 
 
At 250C              At 600C 
0.01%                   8.25% 
0.64%                   23.2% 
2.52%                   52.4% 
 
   At 250C                     At 600C  
   0.732               0.732, 0.803, 1.215 
   0.732               0.732, 0.803, 1.215 
   1.037               0.732, 0.803, 1.215 
 





















           0.826, 1.156, 1.356 
 




   100% 
  
              1.156, 1.490 
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formulation which helps in the better formulation development. The 
current study demonstrates the degradation susceptibility of drugs 
to different stress conditions and thus helps in determining the 
changes in chemical, physical and microbiological properties of the 
drug samples with time. It also helps in understanding the 
mechanism and pathway of degraded product formation and in 
developing a profile reflecting the changes in identity, purity and 
potency of the product. Hence, the method can be recommended for 
routine analysis of Poweromin tablet and Makaradhwaj vatti poly 
herbal formulation containing the drug trimyristin. This method was 
very effective for the estimation of Trimyristin in API and in seed 
extract in particular with the impetus for the future development of 
quality monographs for dosage forms containing Trimyristin.  It 
appears suitable for routine analysis of the drug selectively in the 
presence of their degraded products in individual and in combined 
pharmaceutical formulations in a time efficient manner. 
ABBREVATIONS 
API: Active Pharmaceutical Ingredient (Standard Trimyristin). 
%RSD: Relative Standard deviation. 
ICH: International Conference of Harmonization 
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